Scandinavian Pharmaceuticals ApS: Financial statements 2022
CVR: 41233788
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Scandinavian Pharmaceuticals ApS (CVR 41233788) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -4,804 compared with DKK -2,402 the year before. Equity in the 2022 report amounted to DKK 0.
- Profit/Loss
- DKK -4,804
- Equity
- DKK 0
- Total Assets
- DKK 0
Official annual report
Keep an eye on Scandinavian Pharmaceuticals ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Scandinavian Pharmaceuticals ApS has published its annual report for 2021. The net result was DKK -2,402.
About Scandinavian Pharmaceuticals ApS
Scandinavian Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in Viby J, founded in 2020. The company is registered under the industry Vikarbureauers aktiviteter og anden personaleformidling. The management consists of Ali Jasim Mohammad Jamil. The company is owned by Ali Jasim Mohammad Jamil. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 40,000.